These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21381375)

  • 1. [Immunovac-VP-4 for prevention of acute respiratory diseases in children's communities].
    Egorova NB; Kurbatova EA; Gruber IM; Semenova IB
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):35-40. PubMed ID: 21381375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the multi-component VP-4 vaccine to prevent acute respiratory diseases at preschool children's establishments].
    Egorova NB; Semenov BF; Kurbatova EA; Efremova VN; Gruber IM; Kuz'mina LA; Semenova IB
    Vestn Ross Akad Med Nauk; 2002; (2):29-30. PubMed ID: 11924123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunovac-VP4 vaccine used in complex allergen-specific immunotherapy of patients with hay fever].
    Poddubikova AM; Kostinov MP
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):44-8. PubMed ID: 20799399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antigen-specific activity of a multicomponent vaccine administered orally and subcutaneously].
    Mansurova NL; Chuprinina RP; Egorova NB; Kuz'mina LA; Skorikova IG; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):37-9. PubMed ID: 7539974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The reactogenicity and safety of a multicomponent vaccine (VP-4) in the prevention of acute respiratory diseases in preschoolers].
    Kurbatova EA; Egorova NB; Semenov BF; Efremova VN; Kuz'mina LA; Gruber IM; Semenova IB; Slepoĭ IuD; Samarina OP; Volokh IuV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):42-4. PubMed ID: 10808572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
    Cimadamore N; Agriesti G; Testa A; Borgarello R; Capo G; Crua G
    Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472
    [No Abstract]   [Full Text] [Related]  

  • 7. [Naso-subcutaneous application of the polycomponent vaccine VP-4 for the treatment of patients with bronchial asthma and chronic obstructive bronchitis].
    Antonova LP; Markova TP; Kurbatova EA
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):36-40. PubMed ID: 15636137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunostimulating activity of polycomponent vaccine "Immunovac-VP-4" and grippol after their combined administration].
    Kurbatova EA; Semenov BF; Egorova NB; Efremova VN; Gruber IM; Semenova IB; Kushchenko OM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):34-9. PubMed ID: 15346947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the behavior of intestinal secretory IgA after stimulation with purified antigenic fractions of bacterial origin in infants].
    Iovino A; Bolletti M; Menna A; Maiuri L; Iovino G
    Pediatria (Napoli); 1981 Dec; 89(4):629-45. PubMed ID: 7050885
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunoprophylaxis of acute respiratory diseases with bacterial multicomponent vaccine VP-4 in children at preschool institutions].
    Egorova NB; Semenov BF; Kurbatova EA; Efremova VN; Gruber IM; Kuz'mina LA; Semenova IB; Lytkina IN; Serzhenko SV; Samarina OP; Slepoĭ IuD; Egorova NV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):46-9. PubMed ID: 11550559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of therapeutic polycomponent vaccine "Immunovac VP-4" for the treatment of chronic bacterial prostatitis].
    Bondarenko VM; Vershinin AE; Kucherskiĭ VM; Mitkov VG; Klimova NE; Kurbatova EA; Egorova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (3):39-43. PubMed ID: 15346948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood.
    Mellander L; Carlsson B; Hanson LA
    J Pediatr; 1984 Apr; 104(4):564-8. PubMed ID: 6200589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin levels and function in pre-school children with recurrent respiratory infections.
    Isaacs D; Webster AD; Valman HB
    Clin Exp Immunol; 1984 Nov; 58(2):335-40. PubMed ID: 6094057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The specific activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms].
    Mansurova NL; Egorova NB; Kaverina KG; Poliachenko VM; Lobova EA
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):39-41. PubMed ID: 1882605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The protective activity of a multicomponent vaccine made from the antigens of opportunistic microorganisms when administered orally].
    Egorova NB; Mansurova NL; Kuz'mina LA; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):48-51. PubMed ID: 8067073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
    Bogaert D; Veenhoven RH; Ramdin R; Luijendijk IH; Rijkers GT; Sanders EA; de Groot R; Hermans PW
    Vaccine; 2005 Apr; 23(20):2607-13. PubMed ID: 15780443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine.
    Clancy RL; Cripps AW; Husband AJ; Buckley D
    Infect Immun; 1983 Feb; 39(2):491-6. PubMed ID: 6339379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titres of specific antibodies to poliovirus type 3 and tetanus toxoid in saliva and serum of children with recurrent upper respiratory tract infections.
    Cardinale F; Gentile V; Brunetti L; Hanson LA; Armenio L
    Pediatr Allergy Immunol; 2001 Feb; 12(1):42-8. PubMed ID: 11251864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antigenic activity of vaccines made from opportunistic microorganisms in an experiment to immunize animals by oral and combined methods].
    Efremova VN; Poliachenko VM; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):40-3. PubMed ID: 1441812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for the clinical use of a ribosome-component immune modulator.
    Pregliasco F; Terracciano L; Marcassa S; Zava D; Anselmi G
    Allergy Asthma Proc; 2009; 30 Suppl 1():S5-12. PubMed ID: 19679000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.